2026/2027 COMPREHENSIVE EXAMINATION
ATI Capstone
Pharmacology
2026/2027
An 80-question test bank aligned with 2026–
2027 ATI Capstone testing standards:
scenario-based items, NGN-style clinical
judgment cases, dosage calculations, and
capstone-level rationales.
80 Questions · 7 Sections · Options A–D
25% Recall · 50% Application · 25% Analysis
RATED A+ · NURSING EDUCATION TEST BANK
,ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
COMPREHENSIVE PHARMACOLOGY TEST BANK | NURSING EDUCATION
ATI Capstone Pharmacology 2026/2027
Comprehensive Examination - Rated A+
80 Questions | 7 Sections | Four Options (A-D), One Correct Answer | Cognitive Levels: 25% Recall, 50% Application,
25% Analysis
Each question is followed by the keyed correct answer and a capstone-level rationale covering mechanism of action,
pharmacokinetics, clinical indications, adverse effects, and nursing interventions. Questions marked with [CORRECT]
indicate the keyed option.
SECTION 1: Pharmacokinetics and Pharmacodynamics Questions 1 - 15
Q1: A client with chronic stable angina is prescribed nitroglycerin. The nurse explains that the
sublingual route is selected over the oral route for acute episodes because sublingual administration
produces a faster therapeutic effect. Which pharmacokinetic principle best explains this difference?
A. Sublingual nitroglycerin undergoes extensive hepatic first-pass metabolism, which
concentrates the drug in liver enzymes before systemic release
B. Sublingual absorption delivers the drug directly into the systemic circulation through the oral
mucosa, bypassing the hepatic first-pass effect that deactivates most of an orally administered
dose [CORRECT]
C. Sublingual absorption uses active transport across the blood-brain barrier, which accelerates
coronary vasodilation compared with passive gastric absorption
D. Oral nitroglycerin is completely destroyed by gastric hydrochloric acid, whereas sublingual
nitroglycerin is protected by the enzyme amylase in the mouth
Correct Answer: B
Rationale: Nitroglycerin undergoes extensive first-pass metabolism when swallowed, meaning the liver converts
a large fraction of the oral dose to inactive metabolites before it ever reaches systemic circulation, leaving only
low bioavailability. The sublingual route allows the highly lipid-soluble tablet to dissolve and pass through the rich
capillary network of the oral mucosa directly into the bloodstream, producing effects within 1 to 3 minutes.
Option A incorrectly describes the first-pass effect as concentrating the drug rather than inactivating it. Options C
and D describe nonexistent transport mechanisms and falsely attribute oral loss to gastric acid rather than hepatic
enzyme metabolism.
Aligned with 2026-2027 ATI Capstone Testing Standards 1
,ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
Q2: A nurse is reviewing the concept of bioavailability with a group of nursing students. Which
statement by a student correctly describes bioavailability?
A. Bioavailability is the fraction of the total body water volume into which a drug distributes at
steady state
B. Bioavailability is the speed at which a drug reaches its receptor and produces a maximal
pharmacologic response
C. Bioavailability is the proportion of an administered dose that reaches the systemic circulation
in an unchanged, active form and is available to reach its site of action [CORRECT]
D. Bioavailability is the plasma concentration range in which a drug produces therapeutic
effects without producing toxic effects
Correct Answer: C
Rationale: Bioavailability quantifies the fraction of an administered dose that reaches systemic circulation
unchanged; by definition, intravenous administration provides 100 percent bioavailability because no absorption
barrier exists. Oral formulations typically have lower bioavailability because of incomplete absorption and
first-pass hepatic metabolism. Option A describes volume of distribution, option B describes rate of absorption or
onset, and option D describes the therapeutic range, so each confuses bioavailability with a different
pharmacokinetic or pharmacodynamic parameter. Recognizing these distinctions is essential when nurses
compare oral versus intravenous dosing of the same drug, such as converting IV morphine to oral morphine,
which requires a higher dose because of reduced oral bioavailability.
Q3: A client who has been stable on warfarin is newly prescribed sulfamethoxazole-trimethoprim for
a urinary tract infection. Three days later, the client reports gum bleeding and easy bruising. Which
pharmacokinetic mechanism best explains this finding?
A. Sulfamethoxazole displaces warfarin from plasma protein-binding sites, increasing the
fraction of free, pharmacologically active warfarin in the circulation [CORRECT]
B. Sulfamethoxazole induces hepatic CYP450 enzymes, accelerating the metabolism of
warfarin and lowering its anticoagulant effect
C. Sulfamethoxazole increases the volume of distribution of warfarin, trapping the drug in
adipose tissue away from its sites of action
D. Sulfamethoxazole binds warfarin in the intestinal tract through chelation, preventing
absorption of the anticoagulant
Correct Answer: A
Rationale: Warfarin is approximately 99 percent bound to albumin, so only a small fraction circulates as free,
active drug. Sulfamethoxazole competes for the same albumin-binding sites, displacing warfarin and abruptly
raising the concentration of free warfarin, which produces excessive anticoagulation and bleeding despite an
unchanged total dose. Option B is the opposite of the true effect because these agents inhibit rather than induce
warfarin metabolism, and option D describes chelation interactions seen with tetracyclines and fluoroquinolones.
The nursing response includes monitoring the INR, assessing for bleeding, and reporting the interaction, and this
same displacement mechanism applies when highly protein-bound drugs such as aspirin, phenytoin, or diazepam
are combined with other highly bound agents.
Aligned with 2026-2027 ATI Capstone Testing Standards 2
, ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
Q4: A client begins taking a medication that has a half-life of 24 hours. The provider plans to
evaluate the full therapeutic effect once the drug reaches steady-state plasma concentration. In
approximately how many days should the nurse expect the drug to reach steady state?
A. 1 day
B. 2 days
C. 3 days
D. 4 to 5 days [CORRECT]
Correct Answer: D
Rationale: Steady state is reached after approximately four to five half-lives of regular administration, when the
rate of drug input equals the rate of drug elimination. With a 24-hour half-life, four to five half-lives equal four to
five days, which is why option D is correct and the shorter intervals in options A, B, and C would leave the drug
below its full plateau concentration. Steady-state reasoning guides nurses in counseling clients that full therapeutic
benefit of agents such as antidepressants, amiodarone, or digoxin maintenance dosing is delayed, and it explains
why loading doses are used for critical drugs to bypass this accumulation period. The same mathematics
determines how long a drug effect persists after discontinuation.
Q5: A client taking simvastatin drinks large quantities of grapefruit juice daily and has developed
muscle aches and weakness. Which mechanism explains why grapefruit juice increases the risk of
statin-induced myopathy?
A. Grapefruit juice chelates simvastatin in the intestinal wall, raising circulating drug
concentrations above the therapeutic range
B. Grapefruit juice induces CYP3A4 in the liver, converting simvastatin into a toxic myotoxic
metabolite
C. Grapefruit juice inhibits the intestinal CYP3A4 enzyme system, decreasing first-pass
metabolism of simvastatin and increasing the amount of active drug reaching the systemic
circulation [CORRECT]
D. Grapefruit juice competes with simvastatin for albumin-binding sites, releasing bound drug
and doubling the free serum concentration
Correct Answer: C
Rationale: Simvastatin, lovastatin, and atorvastatin are metabolized by intestinal CYP3A4, and the
furanocoumarins in grapefruit juice irreversibly inhibit that enzyme in the intestinal wall, sharply reducing
presystemic metabolism so that higher active drug levels enter the bloodstream. Elevated statin exposure injures
skeletal muscle, producing myalgia that can progress to rhabdomyolysis with myoglobinuria and acute kidney
injury. Option A describes chelation, which lowers rather than raises absorption, option B describes enzyme
induction, and option D describes protein-binding displacement, so each mechanism is pharmacologically
incorrect for this interaction. The nurse teaches clients on interacting statins to avoid grapefruit juice entirely and
to report muscle pain, tenderness, or dark urine promptly.
Aligned with 2026-2027 ATI Capstone Testing Standards 3
ATI Capstone
Pharmacology
2026/2027
An 80-question test bank aligned with 2026–
2027 ATI Capstone testing standards:
scenario-based items, NGN-style clinical
judgment cases, dosage calculations, and
capstone-level rationales.
80 Questions · 7 Sections · Options A–D
25% Recall · 50% Application · 25% Analysis
RATED A+ · NURSING EDUCATION TEST BANK
,ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
COMPREHENSIVE PHARMACOLOGY TEST BANK | NURSING EDUCATION
ATI Capstone Pharmacology 2026/2027
Comprehensive Examination - Rated A+
80 Questions | 7 Sections | Four Options (A-D), One Correct Answer | Cognitive Levels: 25% Recall, 50% Application,
25% Analysis
Each question is followed by the keyed correct answer and a capstone-level rationale covering mechanism of action,
pharmacokinetics, clinical indications, adverse effects, and nursing interventions. Questions marked with [CORRECT]
indicate the keyed option.
SECTION 1: Pharmacokinetics and Pharmacodynamics Questions 1 - 15
Q1: A client with chronic stable angina is prescribed nitroglycerin. The nurse explains that the
sublingual route is selected over the oral route for acute episodes because sublingual administration
produces a faster therapeutic effect. Which pharmacokinetic principle best explains this difference?
A. Sublingual nitroglycerin undergoes extensive hepatic first-pass metabolism, which
concentrates the drug in liver enzymes before systemic release
B. Sublingual absorption delivers the drug directly into the systemic circulation through the oral
mucosa, bypassing the hepatic first-pass effect that deactivates most of an orally administered
dose [CORRECT]
C. Sublingual absorption uses active transport across the blood-brain barrier, which accelerates
coronary vasodilation compared with passive gastric absorption
D. Oral nitroglycerin is completely destroyed by gastric hydrochloric acid, whereas sublingual
nitroglycerin is protected by the enzyme amylase in the mouth
Correct Answer: B
Rationale: Nitroglycerin undergoes extensive first-pass metabolism when swallowed, meaning the liver converts
a large fraction of the oral dose to inactive metabolites before it ever reaches systemic circulation, leaving only
low bioavailability. The sublingual route allows the highly lipid-soluble tablet to dissolve and pass through the rich
capillary network of the oral mucosa directly into the bloodstream, producing effects within 1 to 3 minutes.
Option A incorrectly describes the first-pass effect as concentrating the drug rather than inactivating it. Options C
and D describe nonexistent transport mechanisms and falsely attribute oral loss to gastric acid rather than hepatic
enzyme metabolism.
Aligned with 2026-2027 ATI Capstone Testing Standards 1
,ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
Q2: A nurse is reviewing the concept of bioavailability with a group of nursing students. Which
statement by a student correctly describes bioavailability?
A. Bioavailability is the fraction of the total body water volume into which a drug distributes at
steady state
B. Bioavailability is the speed at which a drug reaches its receptor and produces a maximal
pharmacologic response
C. Bioavailability is the proportion of an administered dose that reaches the systemic circulation
in an unchanged, active form and is available to reach its site of action [CORRECT]
D. Bioavailability is the plasma concentration range in which a drug produces therapeutic
effects without producing toxic effects
Correct Answer: C
Rationale: Bioavailability quantifies the fraction of an administered dose that reaches systemic circulation
unchanged; by definition, intravenous administration provides 100 percent bioavailability because no absorption
barrier exists. Oral formulations typically have lower bioavailability because of incomplete absorption and
first-pass hepatic metabolism. Option A describes volume of distribution, option B describes rate of absorption or
onset, and option D describes the therapeutic range, so each confuses bioavailability with a different
pharmacokinetic or pharmacodynamic parameter. Recognizing these distinctions is essential when nurses
compare oral versus intravenous dosing of the same drug, such as converting IV morphine to oral morphine,
which requires a higher dose because of reduced oral bioavailability.
Q3: A client who has been stable on warfarin is newly prescribed sulfamethoxazole-trimethoprim for
a urinary tract infection. Three days later, the client reports gum bleeding and easy bruising. Which
pharmacokinetic mechanism best explains this finding?
A. Sulfamethoxazole displaces warfarin from plasma protein-binding sites, increasing the
fraction of free, pharmacologically active warfarin in the circulation [CORRECT]
B. Sulfamethoxazole induces hepatic CYP450 enzymes, accelerating the metabolism of
warfarin and lowering its anticoagulant effect
C. Sulfamethoxazole increases the volume of distribution of warfarin, trapping the drug in
adipose tissue away from its sites of action
D. Sulfamethoxazole binds warfarin in the intestinal tract through chelation, preventing
absorption of the anticoagulant
Correct Answer: A
Rationale: Warfarin is approximately 99 percent bound to albumin, so only a small fraction circulates as free,
active drug. Sulfamethoxazole competes for the same albumin-binding sites, displacing warfarin and abruptly
raising the concentration of free warfarin, which produces excessive anticoagulation and bleeding despite an
unchanged total dose. Option B is the opposite of the true effect because these agents inhibit rather than induce
warfarin metabolism, and option D describes chelation interactions seen with tetracyclines and fluoroquinolones.
The nursing response includes monitoring the INR, assessing for bleeding, and reporting the interaction, and this
same displacement mechanism applies when highly protein-bound drugs such as aspirin, phenytoin, or diazepam
are combined with other highly bound agents.
Aligned with 2026-2027 ATI Capstone Testing Standards 2
, ATI CAPSTONE PHARMACOLOGY 2026/2027 | RATED A+ | COMPREHENSIVE EXAMINATION
Q4: A client begins taking a medication that has a half-life of 24 hours. The provider plans to
evaluate the full therapeutic effect once the drug reaches steady-state plasma concentration. In
approximately how many days should the nurse expect the drug to reach steady state?
A. 1 day
B. 2 days
C. 3 days
D. 4 to 5 days [CORRECT]
Correct Answer: D
Rationale: Steady state is reached after approximately four to five half-lives of regular administration, when the
rate of drug input equals the rate of drug elimination. With a 24-hour half-life, four to five half-lives equal four to
five days, which is why option D is correct and the shorter intervals in options A, B, and C would leave the drug
below its full plateau concentration. Steady-state reasoning guides nurses in counseling clients that full therapeutic
benefit of agents such as antidepressants, amiodarone, or digoxin maintenance dosing is delayed, and it explains
why loading doses are used for critical drugs to bypass this accumulation period. The same mathematics
determines how long a drug effect persists after discontinuation.
Q5: A client taking simvastatin drinks large quantities of grapefruit juice daily and has developed
muscle aches and weakness. Which mechanism explains why grapefruit juice increases the risk of
statin-induced myopathy?
A. Grapefruit juice chelates simvastatin in the intestinal wall, raising circulating drug
concentrations above the therapeutic range
B. Grapefruit juice induces CYP3A4 in the liver, converting simvastatin into a toxic myotoxic
metabolite
C. Grapefruit juice inhibits the intestinal CYP3A4 enzyme system, decreasing first-pass
metabolism of simvastatin and increasing the amount of active drug reaching the systemic
circulation [CORRECT]
D. Grapefruit juice competes with simvastatin for albumin-binding sites, releasing bound drug
and doubling the free serum concentration
Correct Answer: C
Rationale: Simvastatin, lovastatin, and atorvastatin are metabolized by intestinal CYP3A4, and the
furanocoumarins in grapefruit juice irreversibly inhibit that enzyme in the intestinal wall, sharply reducing
presystemic metabolism so that higher active drug levels enter the bloodstream. Elevated statin exposure injures
skeletal muscle, producing myalgia that can progress to rhabdomyolysis with myoglobinuria and acute kidney
injury. Option A describes chelation, which lowers rather than raises absorption, option B describes enzyme
induction, and option D describes protein-binding displacement, so each mechanism is pharmacologically
incorrect for this interaction. The nurse teaches clients on interacting statins to avoid grapefruit juice entirely and
to report muscle pain, tenderness, or dark urine promptly.
Aligned with 2026-2027 ATI Capstone Testing Standards 3
